Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Book Chapter Book Chapter Faculty Publications- Book Chapter Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Metal-Based Nanoparticles for Infectious Diseases and Therapeutics Subject The topic of the resource Antimicrobial activity; Capping agents; Doping; Infectious diseases; Metal-based nanoparticles; Nanomaterials; Peptidoglycan layer; Reactive oxygen species Description An account of the resource Infectious diseases that are easily transmitted by microorganisms like bacteria, protozoa, fungus, etc. are a menace to humans. The greatest threat to human race is to mitigate the impact of these diseases. People with less immunity and children are prone to these diseases. Even healthy people get infected due to its easy transmission. Microorganisms causing these diseases are becoming more resistant to the drugs that are available in the market. So, there is a need to find new therapeutic which is facile, sensitive, and selective, is an important challenge for the medical field and this is where nanotechnology is having a greater chance. Nanoparticles especially metal-based nanoparticles have the ability to act against infectious and non-infectious diseases, this is because of their unique properties like small size, high surface area, etc. They do not have a specific binding site on the bacterial cell, which lead to the failure of bacterial resistant towards the nanoparticle mechanism. There are many nanoparticles which are efficient against particular diseases. In this review we are discussing about the advanced nanomaterials as therapeutics for infectious diseases. We have also discussed about antiviral activities which gives us a ray of hope for the solution of the SARS-COV-2. The Editor(s) (if applicable) and The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd. 2022. Creator An entity primarily responsible for making the resource Baby E.K.; Reji C.; Nidhin M. Source A related resource from which the described resource is derived Nanotechnology for Infectious Diseases, pp. 103-124. Publisher An entity responsible for making the resource available Springer Nature Date A point or period of time associated with an event in the lifecycle of the resource 2022-01-01 Identifier An unambiguous reference to the resource within a given context <a href="https://doi.org/10.1007/978-981-16-9190-4_5" target="_blank" rel="noreferrer noopener">https://doi.org/10.1007/978-981-16-9190-4_5</a> <br /><br /><a href="https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140850791&amp;doi=10.1007%2F978-981-16-9190-4_5&amp;partnerID=40&amp;md5=c9b33342b6b055de921033610563d353" target="_blank" rel="noreferrer noopener">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140850791&amp;doi=10.1007%2f978-981-16-9190-4_5&amp;partnerID=40&amp;md5=c9b33342b6b055de921033610563d353</a> Rights Information about rights held in and over the resource Restricted Access Relation A related resource ISBN: 978-981169190-4; 978-981169189-8 Format The file format, physical medium, or dimensions of the resource Online Language A language of the resource English Type The nature or genre of the resource Book chapter Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Baby E.K., Department of Chemistry, Institute of Chemical Technology, Mumbai, India; Reji C., Department of Chemistry, CHRIST (Deemed to be University), Bengaluru, India; Nidhin M., Department of Chemistry, CHRIST (Deemed to be University), Bengaluru, India